Misexpression of CCAAT/enhancer binding protein beta causes osteopenia

Journal of Endocrinology

Volumn 201, Issue 2, 2009, Pages 263-274

  Zanotti, Stefano ^a   Stadmeyer, Lisa ^a   Smerdel Ramoya, Anna ^a   Durant, Deena ^a   Canalis, Ernesto ^a,b  

^a SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CCAAT ENHANCER BINDING PROTEIN BETA; MESSENGER RNA; OSTEOCALCIN;

ADIPOCYTE; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; BONE DENSITY; BONE MINERALIZATION; CELL COUNT; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE ACTIVITY; GENE DELETION; GENE DUPLICATION; GENE INACTIVATION; GENE MUTATION; GENE OVEREXPRESSION; HEMATOPOIETIC STEM CELL; HETEROZYGOSITY; HUMAN; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOPENIA; PHENOTYPE; PRIORITY JOURNAL; RNA INTERFERENCE; TRANSGENIC MOUSE; WEIGHT REDUCTION; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; COMPARATIVE STUDY; FEMUR; GENETICS; HETEROZYGOTE; HOMOZYGOTE; MALE; METABOLIC BONE DISEASE; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BONE DENSITY; BONE DISEASES, METABOLIC; BONE MARROW CELLS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL DIFFERENTIATION; CELLS, CULTURED; DOWN-REGULATION; FEMALE; FEMUR; HETEROZYGOTE; HOMOZYGOTE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OSTEOBLASTS;

EID: 67649863131     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-08-0514     Document Type: Article

References (58)

1. Bianco P & Gehron RP 2000 Marrow stromal stem cells. Journal of Clinical Invesigation 105 1663-1668.
2. Calkhoven CF, Muller C & Leutz A 2000 Translational control of C/ EBPalpha and C/EBPbeta isoform expression. Genes Development 14 1920-1932.
3. Canalis E, Deregowski V, Pereira RC & Gazzerro E 2005 Signals that determine the fate of osteoblastic cells. Journal of Endocrinological Investigation 28 3-7.
4. Cao Z, Umek RM & McKnight SL 1991 Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Development 5 1538-1552.
5. Cesena TI, Cardinaux JR, Kwok R & Schwartz J 2007 CCAAT/ enhancer-binding protein (C/EBP) beta is acetylated at multiple lysines: acetylation of C/EBPbeta at lysine 39 modulates its ability to activate transcription. Journal of Biological Chemistry 282 956-967.
6. Clarke SL, Robinson CE & Gimble JM 1997 CAAT/enhancer binding proteins directly modulate transcription from the peroxisome proliferator-activated receptor gamma 2 promoter. Biochemical and Biophysical Research Communications 240 99-103.
7. Croniger CM, Millward C, Yang J, Kawai Y, Arinze IJ, Liu S, Harada-Shiba Chakravarty K, Friedman JE, Poli V et al. 2001 Mice with a deletion in the gene for CCAAT/enhancer-binding protein beta have an attenuated response to cAMP and impaired carbohydrate metabolism. Journal of Biological Chemistry 276 629-638.
8. Dahl LK 1952 A simple and sensitive histochemical method for calcium. Proceedings of the Society for Experimental Biology and Medicine 80 474-479.
9. De BF, Rucci N, Del FA, Peruzzi B, Paro R, Longo M, Vivarelli M, Muratori F, Berni S, Ballanti P et al. 2006 Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system. Arthritis and Rheumatism 54 3551-3563.
10. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K & Tuschl T 2001 Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 494-498.
11. Franceschi RT, Ge C, Xiao G, Roca H & Jiang D 2007 Transcriptional regulation of osteoblasts. Annals of the New York Academy of Sciences 1116 196-207.
12. Frendo JL, Xiao G, Fuchs S, Franceschi RT, Karsenty G & Ducy P 1998 Functional hierarchy between two OSE2 elements in the control of osteocalcin gene expression in vivo. Journal of Biological Chemistry 273 30509-30516.
13. Frenkel B, Capparelli C, Van Auken M, Baran D, Bryan J, Stein JL, Stein GS & Lian JB 1997 Activity of the osteocalcin promoter in skeletal sites of transgenic mice and during osteoblast differentiation in bone marrow-derived stromal cell cultures: effects of age and sex. Endocrinology 138 2109-2116.
14. Gazzerro E & Canalis E 2006 Skeletal actions of insulin-like growth factors. Expert Review of Endocrinology and Metabolism 1 47-56.
15. Gazzerro E, Pereira RC, Jorgetti V, Olson S, Economides AN & Canalis E 2005 Skeletal overexpression of gremlin impairs bone formation and causes osteopenia. Endocrinology 146 655-665.
16. Giustina A, Mazziotti G & Canalis E 2008 Growth hormone, insulin-like growth factors, and the skeleton. Endocrine Reviews 29 535-559.
17. Greenbaum LE, LiW, Cressman DE, Peng Y, Ciliberto G, Poli V & Taub RC 1998 CCAATenhancer- binding protein beta is required for normal hepatocyte proliferation in mice after partial hepatectomy. Journal of Clinical Invesigation 102 996-1007.
18. Gutierrez S, Javed A, Tennant DK, van Rees M, Montecino M, Stein GS, Stein JL & Lian JB 2002 CCAAT/enhancer-binding proteins (C/EBP) beta and delta activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression. Journal of Biological Chemistry 277 1316-1323.
19. Harrison JR, Huang YF,Wilson KA, Kelly PL, Adams DJ, Gronowicz GA & Clark SH 2005 Col1a1 promoter-targeted expression of p20 CCAAT enhancer-binding protein beta (C/EBPbeta), a truncated C/EBPbeta isoform, causes osteopenia in transgenic mice. Journal of Biological Chemistry 280 8117-8124.
20. Hata K, Nishimura R, Ueda M, Ikeda F, Matsubara T, Ichida F, Hisada K, Nokubi T, Yamaguchi A & Yoneda T 2005 A CCAAT/enhancer binding protein beta isoform, liver-enriched inhibitory protein, regulates commitment of osteoblasts and adipocytes. Molecular Cell Biology 25 1971-1979.
21. Irwin N 1989 Molecular coning. In Sambrook, pp 9.32-9.36. Ed. J FEMT. New York: Cold Spring Harbor Laboratory Press.
22. Iyer VV, Kadakia TB, McCabe LR & Schwartz RC 2004 CCAAT/ enhancer-binding protein-beta has a role in osteoblast proliferation and differentiation. Experimental Cell Research 295 128-137.
23. Kalajzic Z, Liu P, Kalajzic I, Du Z, Braut A, Mina M, Canalis E & Rowe DW 2002 Directing the expression of a green fluorescent protein transgene in differentiated osteoblasts: comparison between rat type I collagen and rat osteocalcin promoters. Bone 31 654-660.
24. Kouadjo KE, Nishida Y, Cadrin-Girard JF, Yoshioka M & St-Amand J 2007 Housekeeping and tissue-specific genes inmouse tissues. BMC Genomics 8 127.
25. Lane MD, Tang QQ & Jiang MS 1999 Role of the CCAAT enhancer binding proteins (C/EBPs) in adipocyte differentiation. Biochemical and Biophysical Research Communications 266 677-683.
26. Li X, Kim JW, Gronborg M, Urlaub H, Lane MD & Tang QQ 2007 Role of cdk2 in the sequential phosphorylation/activation of C/EBPbeta during adipocyte differentiation. PNAS 104 11597-11602.
27. Lian J, Stewart C, Puchacz E, Mackowiak S, Shalhoub V, Collart D, Zambetti G & Stein G 1989 Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression. PNAS 86 1143-1147.
28. McCarthy TL, CentrellaM& Canalis E 1990 Cortisol inhibits the synthesis of insulin-like growth factor-I in skeletal cells. Endocrinology 126 1569-1575.
29. Nagy TR, Prince CW& Li J 2001 Validation of peripheral dual-energy X-ray absorptiometry for the measurement of bone mineral in intact and excised long bones of rats. Journal of Bone and Mineral Research 16 1682-1687.
30. Nazarenko I, Lowe B, Darfler M, Ikonomi P, Schuster D & Rashtchian A 2002a Multiplex quantitative PCR using self-quenched primers labeled with a single fluorophore. Nucleic Acids Research 30 e37.
31. Nazarenko I, Pires R, Lowe B, Obaidy M & Rashtchian A 2002b Effect of primary and secondary structure of oligodeoxyribonucleotides on the fluorescent properties of conjugated dyes. Nucleic Acids Research 30 2089-2195.
32. Nerlov C 2007 The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. Trends in Cell Biology 17 318-324.
33. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR et al. 1997 Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89 765-771.
34. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM & Recker RR 1987 Bone histomorphometry: standardization of nomenclature, symbols, and units. Reprt of the ASBMR histomorphometry nomenclature committee. Journal of Bone and Mineral Research 2 595-610.
35. Pereira RC, Delany AM & Canalis E 2002 Effects of cortisol and BMP-2 on stromal cell differentiation: correlation with CCAAT-enhancer binding protein expression. Bone 30 685-691.
36. Pereira RC, DelanyAM & Canalis E 2004 CCAAT/enhancer binding protein homologous protein (DDIT3) induces osteoblastic cell differentiation. Endocrinology 145 1952-1960.
37. Pereira RC, Stadmeyer L, Marciniak SJ, Ron D & Canalis E 2006 C/EBP homologous protein is necessary for normal osteoblastic function. Journal of Cellular Biochemistry 97 633-640.
38. Pereira RC, Stadmeyer L, Smith DL, Rydziel S & Canalis E 2007 CCAAT/ enhancer binding protein homologous protein (CHOP) decreases bone formation and causes osteopenia. Bone 40 619-626.
39. Ramji DP & Foka P 2002 CCAAT/enhancer-binding proteins: structure, function and regulation. Biochemistry Journal 365 561-575.
40. Ron D & Habener JF 1992 CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Development 6 439-453.
41. Roodman GD 1997 Mechanisms of bone lesions in multiple myeloma and lymphoma. Cancer 80 1557-1563.
42. Rosen ED, Walkey CJ, Puigserver P & Spiegelman BM 2000 Transcriptional regulation of adipogenesis. Genes Development 14 1293-1307.
43. Screpanti I, Romani L, Musiani P, Modesti A, Fattori E, Lazzaro D, Sellitto C, Scarpa S, Bellavia D & Lattanzio G 1995 Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice. EMBO Journal 14 1932-1941.
44. Sharp PA 2001 RNA interference-2001. Genes Development 15 485-490.
45. Shirakawa K, Maeda S, Gotoh T, Hayashi M, Shinomiya K, Ehata S, Nishimura R, Mori M, Onozaki K, Hayashi H et al. 2006 CCAAT/ enhancer-binding protein homologous protein (CHOP) regulates osteoblast differentiation. Molecular Cell Biology 26 6105-6116.
46. Sims NA, White CP, Sunn KL, Thomas GP, Drummond ML, Morrison NA, Eisman JA & Gardiner EM 1997 Human and murine osteocalcin gene expression: conserved tissue restricted expression and divergent responses to 1,25-dihydroxyvitamin D3 in vivo. Molecular Endocrinology 11 1695-1708.
47. Staiger J, Lueben MJ, Berrigan D, Malik R, Perkins SN, Hursting SD & Johnson PF 2008 C/EBPb regulates body composition, energy balance-related hormones, and tumor growth. Carcinogenesis (in press) DOI: 10.1093/CARCIN/BGN273.
48. Sterneck E, Tessarollo L & Johnson PF 1997 An essential role for C/ EBPbeta in female reproduction. Genes Development 11 2153-2162.
49. Tanaka T, Akira S, Yoshida K, Umemoto M, Yoneda Y, Shirafuji N, Fujiwara H, Suematsu S, Yoshida N & Kishimoto T 1995 Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 80 353-361.
50. Tanaka T, Yoshida N, Kishimoto T & Akira S 1997 Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. EMBO Journal 16 7432-7443.
51. Tang QQ, Gronborg M, Huang H, Kim JW, Otto TC, Pandey A & Lane MD 2005 Sequential phosphorylation of CCAATenhancer-binding protein beta by MAPK and glycogen synthase kinase 3beta is required for adipogenesis. PNAS 102 9766-9771.
52. Tominaga H, Maeda S, Hayashi M, Takeda S, Akira S, Komiya S, Nakamura T, Akiyama H & Imamura T 2008 CCAAT/enhancer-binding protein beta promotes osteoblast differentiation by enhancing Runx2 activity with ATF4. Molecular Biology of the Cell 19 5373-5386.
53. Vinson C, Myakishev M, Acharya A, Mir AA, Moll JR & Bonovich M 2002 Classification of human B-ZIP proteins based on dimerization properties. Molecular Cell Biology 22 6321-6335.
54. Winslow MM, Pan M, Starbuck M, Gallo EM, Deng L, Karsenty G & Crabtree GR 2006 Calcineurin/NFAT signaling in osteoblasts regulates bone mass. Developmental Cell 10 771-782.
55. Wiper-Bergeron N, St-Louis C & Lee JM 2007 CCAAT/enhancer binding protein beta abrogates retinoic acid-induced osteoblast differentiation via repression of Runx2 transcription. Molecular Endocrinology 21 2124-2135.
56. Yakar S, Bouxsein ML, Canalis E, Sun H, Glatt V, Gundberg C, Cohen P, Hwang D, Boisclair Y, LeRoith D et al. 2006 The ternary IGF complex influences postnatal bone acquisition and the skeletal response to intermittent parathyroid hormone. Journal of Endocrinology 189 289-299.
57. Yang TT & Chow CW 2003 Transcription cooperation by NFAT.C/EBP composite enhancer complex. Journal of Biological Chemistry 278 15874-15885.
58. Yang X, Matsuda K, Bialek P, Jacquot S, Masuoka HC, Schinke T, Li L, Brancorsini S, Sassone-Corsi P, Townes TM et al. 2004 ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry syndrome. Cell 117 387-398.